We are live on
!
Find out more
DCP
Distillate Capital Partners Portfolio holdings
AUM
$1.9B
1-Year Est. Return
2.22%
This Fund
S&P 500
This Quarter
Est. Return
+7.54%
1 Year Est. Return
-2.22%
3 Year Est. Return
+17.78%
5 Year Est. Return
+50.1%
10 Year Est. Return
–
AUM
$390K
AUM Growth
-$693K
(-64%)
Cap. Flow
-$730K
Cap. Flow
% of AUM
-187.32%
Top 10 Holdings %
Top 10 Hldgs %
34.93%
Holding
108
New
8
Increased
18
Reduced
4
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pultegroup
PHM
|
+$13.2K |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$12.1K |
| 3 |
GoDaddy
GDDY
|
+$11.7K |
| 4 |
PayPal
PYPL
|
+$11.6K |
| 5 |
Albertsons Companies
ACI
|
+$11.2K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$17.4K |
| 2 |
Halliburton
HAL
|
+$14.8K |
| 3 |
Moderna
MRNA
|
+$14.5K |
| 4 |
Gilead Sciences
GILD
|
+$13.7K |
| 5 |
Steel Dynamics
STLD
|
+$12.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.91% |
| 2 | Healthcare | 16.45% |
| 3 | Industrials | 8.82% |
| 4 | Communication Services | 6.67% |
| 5 | Consumer Discretionary | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Skyworks Solutions
SWKS
$9.54B
| $14.5K | 3.73% |
123
+11
| +10% | +$1.22K |
|
2
Lam Research
LRCX
$365B
| $14.3K | 3.67% |
270
+20
| +8% | +$981 |
|
|
3
Pultegroup
PHM
$24.9B
| $14.2K | 3.65% |
+244
| New | +$13.2K |
|
4
Applied Materials
AMAT
$410B
| $14.1K | 3.63% |
115
+2
| +2% | +$230 |
|
5
Microchip Technology
MCHP
$42.3B
| $13.6K | 3.48% |
162
+6
| +4% | +$478 |
|
6
Broadcom
AVGO
$1.82T
| $13.5K | 3.46% |
210
| – | – |
|
|
7
Alphabet (Google) Class A
GOOGL
$3.99T
| $13.1K | 3.36% |
+126
| New | +$12.1K |
|
8
Westlake Corp
WLK
$9.27B
| $13K | 3.33% |
112
+3
| +3% | +$346 |
|
9
Omnicom Group
OMC
$23.5B
| $12.9K | 3.32% |
137
-19
| -12% | -$1.68K |
|
|
CFLT
10
DELISTED
Confluent
CFLT
| $12.9K | 3.3% |
+61
| New | +$1.41K |
|
11
PACCAR
PCAR
$70.2B
| $12.6K | 3.23% |
172
-1
| -0.6% | -$72 |
|
12
Cisco
CSCO
$452B
| $12.4K | 3.18% |
237
-2
| -0.8% | -$98 |
|
13
Regeneron Pharmaceuticals
REGN
$69.9B
| $12.3K | 3.16% |
15
+1
| +7% | +$754 |
|
14
Snap-on
SNA
$21.1B
| $12.1K | 3.11% |
49
+1
| +2% | +$244 |
|
15
Celanese
CE
$4.87B
| $12K | 3.07% |
110
+6
| +6% | +$693 |
|
16
Cognizant
CTSH
$22.3B
| $11.9K | 3.07% |
196
+29
| +17% | +$1.82K |
|
17
NetApp
NTAP
$33.3B
| $11.9K | 3.05% |
186
+32
| +21% | +$2.07K |
|
18
Amdocs
DOX
$5.64B
| $11.8K | 3.03% |
123
+1
| +0.8% | +$93 |
|
|
19
GoDaddy
GDDY
$12.8B
| $11.7K | 3.01% |
+151
| New | +$11.7K |
|
|
20
PayPal
PYPL
$49.5B
| $11.5K | 2.94% |
+151
| New | +$11.6K |
|
21
Diamondback Energy
FANG
$55.1B
| $11.4K | 2.91% |
84
+7
| +9% | +$975 |
|
|
22
Albertsons Companies
ACI
$5.57B
| $11.3K | 2.9% |
+544
| New | +$11.2K |
|
23
AbbVie
ABBV
$454B
| $11.2K | 2.86% |
70
-1
| -1% | -$153 |
|
24
NVR
NVR
$16.9B
| $11.1K | 2.86% |
2
| – | – |
|
25
McKesson
MCK
$99.5B
| $10.7K | 2.74% |
30
+1
| +3% | +$361 |
|
Similar funds
EP
FTCM
SIC
OPCM
IAN
BOH
VC
MC
Distillate Capital Partners's Q1 2023 Portfolio in Review
As of Q1 2023, Distillate Capital Partners held 108 positions worth $390K, down 64% from $1.08M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Distillate Capital Partners withdrew a net $730K in Q1 2023, closing 75 positions and reducing 4 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $17.4K position sold in full.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Distillate Capital Partners opened a new position in Pultegroup worth $14.2K.
- Distillate Capital Partners's largest Q1 2023 buy was Pultegroup: 244 shares worth $14.2K.
- Distillate Capital Partners added most to Fidelity National Information Services in Q1 2023, an estimated $2.34K increase.
- Distillate Capital Partners's biggest Q1 2023 reduction was Omnicom Group, cutting an estimated $1.68K.
- Distillate Capital Partners fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, selling an estimated $17.4K.
- Distillate Capital Partners's ten largest holdings make up 35% of its $390K portfolio in Q1 2023.
- Distillate Capital Partners opened 8 new positions and closed 75 in Q1 2023.
- Distillate Capital Partners's portfolio value fell 64% quarter-over-quarter to $390K.
Based on Distillate Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.